Sep 6, 2026 · Sports, Health & Nutrition Daily Digest
A digest of sports, fitness, wellness, and nutrition developments compiled for Sep 6, 2026, with summaries, links, and commentary.
I. Nutrition & Diet
1. NutriNet-Santé cohort: Each extra hour of “eating jetlag” linked to higher CVD and coronary risk in men (nutrition/circadian)
Summary:
Communications Medicine (DOI: 10.1038/s43856-026-01758-5; INRAE/Inserm et al.) analyzed 104,806 adults in the French NutriNet-Santé cohort (~79% women; mean age ~42.7 years), defining eating jetlag as the absolute weekday–weekend difference in first and last caloric intake times. Over a median ~8.1 years of follow-up, each additional hour of eating jetlag in men was associated with higher cardiovascular disease risk (HR ≈1.14, 95% CI 1.05–1.23) and coronary heart disease risk (HR ≈1.21, 1.11–1.33). Versus a “maintenance” weekend schedule, both advancing and delaying the weekend eating window tracked with higher risk in men. No significant association was seen in women. Associations persisted after adjustment for diet quality, bedtime, total sleep, and social jetlag. Observational; aligning weekend mealtimes is not yet proven to cut events.
Links:
- Communications Medicine — Eating jetlag and CVD
- INRAE — Eating Jetlag and the Risk of Cardiovascular Disease
Commentary:
For men with weekday work schedules, keeping weekend first/last meal times closer to weekday timing is a low-cost circadian hygiene habit—evidence is not yet strong enough for a rigid “meal clock prescription.”
2. HPFS cohort: After nonmetastatic prostate cancer, higher saturated/animal fat linked to all-cause death; plant-fat swaps look favorable (nutrition)
Summary:
JAMA Network Open (DOI: 10.1001/jamanetworkopen.2026.30693; Harvard T.H. Chan School of Public Health and the Research Institute of the McGill University Health Centre; published Sep 2, 2026) followed 4,884 men with nonmetastatic prostate cancer in the Health Professionals Follow-Up Study for a median ~12.8 years and confirmed 3,040 deaths from any cause (803 cardiovascular, 499 other cancers, 441 prostate cancer). Highest versus lowest quintile of saturated fat: all-cause mortality HR ≈1.24 (1.05–1.47) and cardiovascular mortality HR ≈1.42 (1.02–1.98), without a clear link to prostate-cancer-specific death. Modelled substitution of ~10% of energy from animal fat with plant fat yielded HR ≈0.84 for all-cause death; substituting ~5% of energy from saturated fat with monounsaturated fat yielded HR ≈0.80. Observational substitution analyses; predominantly U.S. white men.
Links:
Commentary:
Long-term prostate-cancer survivors should treat heart health as part of survivorship—swapping some red meat/butter for olive oil, nuts, and seeds fits the evidence better than “zero fat.”
3. WashU feeding RCT: With matched ~10% weight loss, a ketogenic diet cut liver fat and improved hepatic insulin sensitivity more than Mediterranean or low-fat plant-forward diets (nutrition)
Summary:
Cell Metabolism (DOI: 10.1016/j.cmet.2026.07.020; Washington University School of Medicine Klein/Petersen; Aug 27, 2026) randomized adults with metabolically unhealthy obesity (obesity plus prediabetes and hepatic steatosis) to a very-low-carbohydrate ketogenic, Mediterranean, or very-low-fat plant-forward diet with all food provided for ~4–5 months and matched ~10% weight loss. Muscle insulin sensitivity rose ~50% in all groups; hepatic insulin sensitivity improved about two- to three-fold more on keto, and intrahepatic triglyceride fell ~67% versus ~45% on the other diets. Institutional coverage reported prediabetes remission in about 50% (keto) versus 29% (Mediterranean) versus 7% (high-carb plant-forward); LDL-C, apoB, and 24-hour triglycerides did not differ significantly among groups. Small, highly controlled feeding trial; long-term adherence and the full lipoprotein risk picture still need longer follow-up.
Links:
Commentary:
If the goal in obesity–prediabetes–fatty liver is liver fat and glucose control, matched weight loss on very-low-carb may add hepatic benefit; if the goal is weight loss alone, all three patterns improved muscle insulin sensitivity—choose what you can sustain and monitor lipids on.
4. 24-week Chinese RCT: A CGM-guided personalized postprandial diet outperformed a standard diabetic diet (nutrition)
Summary:
Food Science and Human Wellness (DOI: 10.26599/FSHW.2026.9250961) randomized 175 Chinese adults with prediabetes or unmedicated type 2 diabetes to a CGM-guided personalized postprandial-targeting (PPT) diet or a standardized Chinese Diabetic Diet (CDD) for 24 weeks. Versus CDD, PPT produced a between-group HbA1c difference of about −0.4% (−0.55, −0.25), fasting glucose about −0.37 mmol/L, and 2-h OGTT about −1.04 mmol/L; postprandial glucose iAUC fell more; carbohydrate intake declined more sharply (~244→148 g/day vs 240→181 g/day); LDL-C, triglycerides, and weight loss (−6.83 vs −0.55 kg) also favored PPT. Open-label personalized intervention; long-term sustainability and cost-effectiveness remain open questions.
Links:
Commentary:
If you have access to CGM, feed “which meals spike glucose” back into menu edits; without a device, a standard diabetes-style cut in refined carbs remains the floor.
II. Exercise & Training Science
5. 8-week within-subject RCT: In trained men, autoregulated BFR cuffs added no extra hypertrophy or strength versus non-autoregulated BFR (training)
Summary:
Frontiers in Physiology (DOI: 10.3389/fphys.2026.1772708) randomized 21 resistance-trained men (≥3 years) in a within-subject design: twice-weekly single-leg squats and knee extensions for 8 weeks, one limb under autoregulated BFR (AUTO) and the contralateral limb under non-autoregulated BFR (NONAUTO). Both conditions increased rectus femoris/vastus lateralis thickness and CSA and 1RM on both lifts, with no between-condition differences; RPE and discomfort fell over time similarly. No adverse events were reported. Young trained men only—do not extrapolate to novices or women.
Links:
Commentary:
If you already use blood-flow restriction correctly, skip paying a premium for “smart autoregulation”—spend on consistent cuff pressure and completable training volume instead.
6. 8-week RCT: In sedentary young men, multiple-set resistance training beat single-set for hypertrophy and strength (training)
Summary:
BMC Sports Science, Medicine and Rehabilitation (DOI: 10.1186/s13102-026-01874-8) randomized 34 sedentary men to single-set (SS), three-set (MS), or control; training was twice weekly for 8 weeks across seven exercises with up to 10 reps per set. MS increased leg muscle CSA by ~11.3%, exceeding SS (6–8%); bench-press and squat 1RM gains were also larger (+19.8% and ~+14.8%); vertical jump and Yo-Yo IR1 improved more with MS. SS still beat control on most performance outcomes. Small sample of untrained men only—early-phase dose–response.
Links:
Commentary:
Starting strength training: do 2–3 sets when time allows; a single set still beats nothing, but do not expect equal hypertrophy speed.
7. RCT meta-analysis: In diabesity, aerobic training favors fasting glucose and fitness; resistance training favors lean-mass retention (training/chronic disease)
Summary:
Journal of Sports Science and Medicine (DOI: 10.52082/jssm.2026.637) systematically reviewed and meta-analyzed aerobic exercise (AE) versus resistance training (RT) in adults with type 2 diabetes plus obesity (diabesity), searching through April 2026 across 23 RCTs (1,184 adults). Versus RT, AE lowered fasting blood glucose (MD ≈ −0.89 mmol/L) and raised cardiorespiratory fitness (MD ≈ +1.78 mL/kg/min) but was less favorable for body-fat % and fat-free mass retention (FFM MD ≈ −0.86 kg). Most lipid and hemodynamic outcomes did not differ. Certainty of evidence varied; authors argue for goal-directed complementary prescriptions rather than either/or.
Links:
Commentary:
For diabetes-with-obesity: keep aerobic work for glucose and stamina; add resistance to protect muscle in a calorie deficit—ideal weeks include both, not a team jersey.
8. Three-level meta-analysis: Polyphenol interventions show a small effect on post-exercise soreness; effects on damage biomarkers and performance recovery remain uncertain (training/recovery)
Summary:
Frontiers in Nutrition (DOI: 10.3389/fnut.2026.1941705) pooled 24 RCTs (195 effect sizes) on polyphenol interventions after exercise-induced muscle damage. Pain/soreness: g ≈ 0.252 (95% CI 0.049–0.454); muscle-damage biomarkers g ≈ 0.097 (CI crossed null); performance g ≈ 0.238 (CI crossed null, p ≈ 0.065). No robust differences across prespecified recovery windows or supplementation strategies; certainty was mostly low to very low. A small perceptual soreness benefit is possible—not a settled claim of faster functional recovery.
Links:
Commentary:
Tart cherry or pomegranate polyphenols are a weak-evidence option for soreness management; sleep, total protein, and load management still set return-to-training pace.
III. Public Health & Disease Prevention
9. 2026–2027 respiratory season: CDC updates influenza clinical considerations; AAFP and peers issue flu/RSV/COVID guidance (guidelines)
Summary:
On Sep 1, 2026, CDC posted Interim Clinical Considerations for U.S. seasonal influenza vaccines, stating that influenza recommendations from the July 2025 immunization schedule remain in effect for 2026–2027; for most people needing one dose, September–October is the preferred window, and July–August vaccination is generally discouraged because of potential late-season waning. Concurrently, APhA summarized updated 2026–2027 COVID-19, influenza, and RSV recommendations from AAFP, AAP, ACOG, and IDSA. AAFP adult guidance emphasizes annual influenza plus an updated COVID vaccine for adults ≥19 years, preferential enhanced influenza vaccines for adults ≥65 when available without delaying vaccination to wait for one, and age-/risk-stratified COVID additional doses and RSV. U.S. practice guidance—apply alongside local immunization policy.
Links:
- CDC — Interim Clinical Considerations for seasonal influenza vaccines
- APhA — Updated 2026–2027 respiratory virus vaccine recommendations
Commentary:
With Northern Hemisphere autumn arriving, put flu shots on the September–October calendar and ask about COVID/RSV eligibility if you are older or chronically ill—timing beats chasing the absolute earliest dose.
IV. Sleep & Mental Health
10. Review: Sleep disturbances in adolescents and young adults as early observable markers of psychotic disorders (sleep)
Summary:
Frontiers in Synaptic Neuroscience (Sep 4, 2026; DOI: 10.3389/fnsyn.2026.1949833) reviews the high prevalence of sleep problems (insomnia, circadian disruption, fragmented sleep) in clinical high-risk for psychosis (CHR-P) and early schizophrenia (literature estimates up to ~70% and ~80%, respectively), overlapping dopaminergic/stress pathways, screening tools (questionnaires, actigraphy), and sleep-focused interventions such as CBT as potentially modifiable targets. Narrative review, not new causal cohort evidence; authors call for longitudinal multimodal studies and personalized prevention strategies.
Links:
Commentary:
When teens show persistent insomnia or marked delayed schedules plus mood/perceptual changes, fold sleep assessment into early mental-health pathways rather than dismissing it as “just staying up late.”
V. Evidence Clarification / Sports Medicine
11. Double-blind crossover RCT: CLE-guided individualized exclusion diets did not beat sham exclusion for IBS symptoms (evidence clarification)
Summary:
Gastroenterology (DOI: 10.1053/j.gastro.2026.08.026; Sep 1, 2026; KU Leuven et al.) randomized Rome-criteria IBS patients in a double-blind crossover: after CLE identified foods eliciting mucosal changes, a true exclusion diet versus a sham diet excluding non-reactive foods, each for ~4 weeks. Clinical response (IBS-SSS drop ≥50) was about 42% versus 36% (OR ≈1.33, p ≈0.60), with similar score reductions. Healthy controls can also show CLE mucosal changes, suggesting nonspecific reactivity. Findings challenge the clinical added value of CLE-guided “precision avoidance.”
Links:
Commentary:
Do not rush to pay for endoscope-guided food bans in IBS; discuss better-supported paths (e.g., clinician-guided low FODMAP) and avoid overly restrictive diets that risk nutrient shortfalls.
12. RCT meta-analysis: Neuromuscular warm-ups in youth soccer may reduce ankle injuries; overall and knee prevention evidence remains inconclusive (sports medicine)
Summary:
Frontiers in Sports and Active Living (DOI: 10.3389/fspor.2026.1853354) systematically reviewed and meta-analyzed neuromuscular training (NMT) warm-ups in soccer players aged 8–18, searching through October 2025 across five RCTs (n ≈ 6,447). Pooled exposure-based outcomes: all lower-limb injuries IRR ≈ 0.54 (95% CI 0.20–1.45; high heterogeneity) and knee injuries IRR ≈ 0.86 (0.62–1.19), neither statistically significant. One trial with exposure data reported lower ankle, ligament, and muscle injury rates; remaining trials narratively favored NMT. Authors conclude a possible ankle benefit signal, while overall and knee prevention remain inconclusive.
Links:
Commentary:
Youth programs should still keep NMT warm-ups in the pre-session routine—but do not market them as proven blanket ACL prevention; adherence beats swapping to flashier drills.
Today's Summary
- Diet: Weekend eating jetlag tracks with male CVD risk; fat source matters after prostate cancer; matched weight loss on keto may favor liver fat; a Chinese CGM-personalized menu beat a standard diabetic diet on glycemic, lipid, and weight outcomes.
- Training: Autoregulated BFR added nothing; novices gain more from multiple sets; aerobic and resistance should be complementary in diabesity; polyphenols offer only a small soreness signal.
- Public health & sleep: Schedule 2026–2027 flu/respiratory vaccines for September–October; persistent adolescent sleep disruption warrants attention as an early mental-health signal.
- Clarification: CLE “precision exclusion” failed a blinded test; youth NMT warm-ups are worth doing, but overall injury-prevention claims need stronger exposure data.
Daily Framing:
Today in the sport/health/nutrition cycle was a “circadian timing and fat-quality calibration day”—align meal timing and fat sources, match macronutrient choice to liver–glucose goals, pair aerobic and resistance work for chronic disease, and cool expectations for endoscope diets and recovery supplements.
This digest is compiled from real-time search results and is for reference only.